Post-Market Surveillance Study Evaluating the Real-World User Experience

A Post-Market Surveillance Study Evaluating the Real-World User Experience and Effectiveness of an Integrated Menstrual Pain Modulation Therapy (IMPMT) - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2026/03/106778

Enrollment

Registered

2026-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Women presenting with symptoms consistent with dysmenorrhea symptoms. Total 50 participants will be enrolled in the study and followed across two consecutive menstrual cycles, allowing for multiple symptom observations per participant during the peak. dysmenorrhea period.

Exclusion criteria

Exclusion criteria: Female less than 18 years old and women more than 50 years of age or menopaused women

Design outcomes

Primary

Measure	Time frame
The primary outcomes of the study will focus on evaluating the effectiveness of the integrated menstrual pain modulation therapy in alleviating menstrual pain and improving dysmenorrhea severity.Timepoint: at baseline, 3 days, 2 weeks, 4 weeks & 8 weeks	—

Secondary

Measure	Time frame
Secondary outcomes will evaluate the broader impact of the integrated menstrual pain management approach on associated symptoms, functional ability, & overall participant experience.Timepoint: at baseline, 3 days, 2 weeks, 4 weeks & 8 weeks	—

Countries

India

Contacts

Public ContactSharmistha Mondal

Mithra Multispeciality Hospital

drsharmisthamondal@gmail.com9916464776

Outcome results